Literature DB >> 12404165

Measles epidemic in the Netherlands, 1999-2000.

Susan van den Hof1, Marina A E Conyn-van Spaendonck, Jim E van Steenbergen.   

Abstract

In 1999-2000, a measles epidemic occurred in The Netherlands, with 3292 reported cases; 94% of the affected patients had not been vaccinated. Only 1 patient had received 2 doses of vaccine. Three patients died, and 16% had complications. For the unvaccinated population, the incidence per 1000 inhabitants 15 months to 14 years old increased from 83 (95% confidence interval [CI], 53-113), in municipalities with vaccine coverage rates < or =90%, to 200 (95% CI, 153-247), in municipalities with coverage rates >95%; for the vaccinated population, the incidence increased from 0.2 (95% CI, 0.1-0.4) to 1.4 (95% CI, 0.9-1.9). Unvaccinated individuals were 224 times (95% CI, 148-460 times) more likely to acquire measles than were vaccinated individuals; the relative risk increased with decreasing vaccine coverage. Herd immunity outside unvaccinated clusters was high enough to prevent further transmission. More case patients came from the vaccine-accepting population living among unvaccinated clusters than from individuals who declined vaccination and who lived among the vaccine-accepting population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404165     DOI: 10.1086/344894

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Vaccination: the present and the future.

Authors:  Saheli Sadanand
Journal:  Yale J Biol Med       Date:  2011-12

2.  Networks of influence and infection: parental choices and childhood disease.

Authors:  Ken T D Eames
Journal:  J R Soc Interface       Date:  2009-05-15       Impact factor: 4.118

Review 3.  A global perspective of vaccination of healthcare personnel against measles: systematic review.

Authors:  Amy Parker Fiebelkorn; Jane F Seward; Walter A Orenstein
Journal:  Vaccine       Date:  2013-11-24       Impact factor: 3.641

4.  Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.

Authors:  Laura K White; Jeong-Joong Yoon; Jin K Lee; Aiming Sun; Yuhong Du; Haian Fu; James P Snyder; Richard K Plemper
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

5.  High-throughput screening-based identification of paramyxovirus inhibitors.

Authors:  Jeong-Joong Yoon; Dhruv Chawla; Tanja Paal; Maina Ndungu; Yuhong Du; Serdar Kurtkaya; Aiming Sun; James P Snyder; Richard K Plemper
Journal:  J Biomol Screen       Date:  2008-07-14

6.  Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

Authors:  Sandra Waaijenborg; Susan J M Hahné; Liesbeth Mollema; Gaby P Smits; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker; Jacco Wallinga
Journal:  J Infect Dis       Date:  2013-05-08       Impact factor: 5.226

7.  Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

8.  How orthodox protestant parents decide on the vaccination of their children: a qualitative study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Giovanna van Ijzendoorn; Wilke J C van Ansem; Koos van der Velden; Marlies E J L Hulscher
Journal:  BMC Public Health       Date:  2012-06-06       Impact factor: 3.295

9.  How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Giovanna van IJzendoorn; Wilke J C van Ansem; Glyn Elwyn; Koos van der Velden; Marlies E J L Hulscher
Journal:  BMC Health Serv Res       Date:  2012-08-01       Impact factor: 2.655

10.  The role of religious leaders in promoting acceptance of vaccination within a minority group: a qualitative study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Said Kerrar; Koos van der Velden; Marlies E J L Hulscher
Journal:  BMC Public Health       Date:  2013-05-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.